Fig. 5: Local and systemic reactions reported after the third vaccine dose.
From: Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose
Local symptoms included local pain (reported by 3,058 of 3,611 HCWs), swelling (n = 685), redness (n = 445) and itching (n = 11). Neurologic symptoms included paresthesia (n = 138) and facial nerve palsy (n = 17). Other adverse reactions included abnormal laboratory results, such as elevated C-reactive protein, elevated thyroid-stimulating hormone, hyponatremia or leukopenia (n = 1 each). Other symptoms included herpes labialis (n = 3) and report of new-onset psoriasis (n = 1). GI, gastrointestinal.
